Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials

Lancet

Volumn 368, Issue 9539, 2006, Pages 929-937

  Pryor, Jon L ^a   Althof, Stanley E ^b   Steidle, Christopher ^c   Rosen, Raymond C ^d   Hellstrom, Wayne JG ^e   Shabsigh, Ridwan ^f   Miloslavsky, Maja ^g   Kell, Sherron ^g  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NorthEast Indiana Research LLC   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f Och Spine at New York Presbyterian Hospitals   (United States)

^g ALZA CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPOXETINE; PLACEBO;

ABSENCE OF SIDE EFFECTS; ACCIDENTAL INJURY; ADULT; AGED; ANKLE SPRAIN; ANXIETY DISORDER; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIARRHEA; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EJACULATION DISORDER; ERECTILE DYSFUNCTION; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NAUSEA; NERVOUSNESS; PREMATURE EJACULATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONIN SYNDROME; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; SWEATING; SYNCOPE; SYSTEMATIC REVIEW; TRAFFIC ACCIDENT; VOMITING;

EID: 33748316794     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69373-2     Document Type: Article

References (38)

1. Rowland D., Perelman M., Althof S., et al. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 1 (2004) 225-232
2. Rosen R. The premature ejaculation prevalence and attitudes (PEPA) survey: a multi-national survey. J Sex Med 1 suppl 1 (2004) 57-58
3. Laumann E., Paik A., and Rosen R. Sexual dysfunction in the United States: prevalence and predictors. JAMA 281 (1999) 537-544
4. Symonds T., Roblin D., Hart K., and Althof S. How does premature ejaculation impact a man's life?. J Sex Marital Ther 29 (2003) 361-370
5. Montague D., Jarow J., Broderick G., et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 172 (2004) 290-294
6. McCabe M. Intimacy and quality of life among sexually dysfunctional men and women. J Sex Marital Ther 23 (1997) 276-290
7. Byers E., and Grenier G. Premature or rapid ejaculation: heterosexual couples' perceptions of men's ejaculatory behavior. Arch Sex Behav 32 (2003) 261-270
8. McMahon C. Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo controlled crossover study. J Urol 159 (1998) 1935-1938
9. McMahon C., and Touma K. Treatment of premature ejaculation with paroxetine hydrochloride. Int J Impot Res 11 (1999) 241-246
10. McMahon C., and Touma K. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies. J Urol 161 (1999) 1826-1830
11. Waldinger M., Hengeveld M., Zwinderman A., and Olivier B. Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 18 (1998) 275-281
12. Kara H., Aydin S., Yucel M., Agargun M., Odabas O., and Yilmaz Y. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol 156 (1996) 1631-1632
13. Hiemke C., and Härtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85 (2000) 11-28
14. Rosen R., Lane R., and Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 19 (1999) 67-85
15. Montejo-Gonzales A., Llorca G., Izquierdo J., et al. SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 23 (1997) 176-194
16. Williams V., Baldwin D., Hogue S., Fehnel S., Hollis K., and Edin H. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry 67 (2006) 204-210
17. Hu X., Bull S., Hunkeler E., et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 65 (2004) 959-965
18. Goldstein B., and Goodnick P. Selective serotonin reuptake inhibitors in the treatment of affective disorders-III. Tolerability, safety and pharmacoeconomics. J Psychopharmacol 12 3 suppl B (1998) S55-S87
19. Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf 20 (1999) 277-287
20. Lane R., and Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 17 (1997) 208-221
21. Waldinger M., Berendsen H., Blok B., Olivier B., and Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 92 (1998) 111-118
22. Waldinger M. The neurobiological approach to premature ejaculation. J Urol 168 (2002) 2359-2367
23. Gengo P., Giuliano F., McKenna K., et al. Monoaminergic transporter binding and inhibition profile of dapoxetine, a medication for the treatment of premature ejaculation. J Urol 173 suppl 4 (2005) 239
24. Modi N., Dresser M., Simon M., Lin D., Desai D., and Gupta S. Single- and multiple-dose pharmacokinetics of dapoxetine hydrochloride, a novel agent for the treatment of premature ejaculation. J Clin Pharmacol 46 (2006) 301-309
25. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (2000), American Psychiatric Association, Washington, DC text revision
26. Patrick D., Althof S., Pryor J., et al. Premature ejaculation: an observational study of men and their partners. J Sex Med 2 (2005) 358-367
27. Hellstrom W., Althof S., Gittelman M., et al. Dapoxetine for the treatment of men with premature ejaculation (PE): dose-finding analysis. J Urol 173 suppl 4 (2005) 238
28. Rowland D., deGouvea Brazao C., Strassberg D., and Slob A. Ejaculatory latency and control in men with premature ejaculation: a detailed analysis across sexual activities using multiple sources of information. J Psychosom Res 48 (2000) 69-77
29. Grenier G., and Byers E. Rapid ejaculation: a review of conceptual, etiological, and treatment issues. Arch Sex Behav 24 (1995) 447-472
30. Guyatt G., Osoba D., Wu A., Wyrwich K., Norman G., and Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77 (2002) 371-383
31. Patrick D., Martin M., Bushnell D., Yalcin I., Hawner H., and Buesching D. Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL). Urology 53 (1999) 71-76
32. Waldinger M., Zwinderman A., Schweitzer D., and Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res 16 (2004) 369-381
33. Waldinger M. Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment. World J Urol 23 (2005) 102-108
34. American Urological Association. Pharmacologic treatment of premature ejaculation (PE) appendices. http://www.auanet.org/timssnet/products/guidelines/main_reports/pme/appendices.pdf (accessed Jul 7, 2006)
35. Anon. Physician's desk reference. 58th ed. (2004), Thomson Healthcare, Montvale, NJ
36. Anon. Paxil (paroxetine hydrochloride) [prescribing information] (2005), GlaxoSmithKline, Research Triangle Park, NC
37. Anon. Viagra (sildenafil citrate) [prescribing information] (2005), Pfizer Inc, New York, NY
38. Anon. Levitra (vardenafil HCl) [prescribing information] (2005), Bayer Pharmaceuticals Corporation, West Haven, CT